OPTIMI HEALTH CORP. (F:8BN) — Market Cap & Net Worth
Market Cap & Net Worth: OPTIMI HEALTH CORP. (8BN)
OPTIMI HEALTH CORP. (F:8BN) has a market capitalization of $17.99 Million (€15.39 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #25359 globally and #2190 in its home market, demonstrating a -5.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OPTIMI HEALTH CORP.'s stock price €0.20 by its total outstanding shares 96776919 (96.78 Million). Analyse OPTIMI HEALTH CORP. operating cash flow efficiency to see how efficiently the company converts income to cash.
OPTIMI HEALTH CORP. Market Cap History: 2021 to 2026
OPTIMI HEALTH CORP.'s market capitalization history from 2021 to 2026. Data shows change from $36.54 Million to $23.08 Million (-15.25% CAGR).
OPTIMI HEALTH CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OPTIMI HEALTH CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
52.55x
OPTIMI HEALTH CORP.'s market cap is 52.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $18.31 Million | $80.72K | -$7.35 Million | 226.80x | N/A |
| 2023 | $12.90 Million | $181.09K | -$5.19 Million | 71.23x | N/A |
| 2024 | $16.29 Million | $389.85K | -$6.04 Million | 41.79x | N/A |
| 2025 | $22.40 Million | $426.30K | -$3.71 Million | 52.55x | N/A |
Competitor Companies of 8BN by Market Capitalization
Companies near OPTIMI HEALTH CORP. in the global market cap rankings as of May 5, 2026.
Key companies related to OPTIMI HEALTH CORP. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #497 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #524 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #531 globally with a market cap of $49.66 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #571 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #497 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #524 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #531 | Zoetis Inc | NYSE:ZTS | $49.66 Billion | $112.68 |
| #571 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $41.87 |
OPTIMI HEALTH CORP. Historical Marketcap From 2021 to 2026
Between 2021 and today, OPTIMI HEALTH CORP.'s market cap moved from $36.54 Million to $ 23.08 Million, with a yearly change of -15.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €23.08 Million | +3.03% |
| 2025 | €22.40 Million | +37.50% |
| 2024 | €16.29 Million | +26.32% |
| 2023 | €12.90 Million | -29.54% |
| 2022 | €18.31 Million | -49.91% |
| 2021 | €36.54 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of OPTIMI HEALTH CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.99 Million USD |
| MoneyControl | $17.99 Million USD |
| MarketWatch | $17.99 Million USD |
| marketcap.company | $17.99 Million USD |
| Reuters | $17.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of m… Read more